How early can cognitive decline be detected?

BMJ (Online)

Volumn 344, Issue 7840, 2012, Pages

  Grodstein, Francine ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; COGNITION; COGNITIVE DEFECT; COMPUTER; DEMENTIA; EDITORIAL; FUNCTIONAL ASSESSMENT; HUMAN; MEDICAL RESEARCH; NERVE DEGENERATION; NEUROLOGIC EXAMINATION; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TELEPHONE;

AGING; COGNITION DISORDERS; FEMALE; HUMANS; MALE;

EID: 84859004507     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.d7652     Document Type: Editorial

References (6)

1. Singh-Manoux A, Kivimaki M, Glymour MM, Elbaz A, Berr C, Ebmeier KP, et al. Timing of onset of cognitive decline: results from Whitehall II prospective cohort study. BMJ 2012;344:d7622.
2. Elias MF, Beiser A, Wolf PA, Au R, White RF, D'Agostino RB. The preclinical phase of Alzheimer disease: a 22-year prospective study of the Framingham cohort. Arch Neurol 2000;57:808-13. (Pubitemid 30397182)
3. Powell MR, Smith GE, Knopman DS, Parisi JE, Boeve BF, Petersen RC, et al. Cognitive measures predict pathologic Alzheimer disease. Arch Neurol 2006;63:865-8. (Pubitemid 43882295)
4. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:280-92.
5. Evans DA, Grodstein F, Loewenstein D, Kaye J, Weintraub S. Reducing case ascertainment costs in U.S. population studies of Alzheimer's disease, dementia, and cognitive impairment - part 2. Alzheimers Dement 2011;7:110-23.
6. Wild K, Howieson D, Webbe F, Seelye A, Kaye J. Status of computerized cognitive testing in aging: a systematic review. Alzheimers Dement 2008;4:428-37.